Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15

Monoclonal antibody (MAb) FC-2.15 recognizes Lewis x antigen (Le(x)-Ag) expressed on the cell surface of most human breast cancer cells. FC-2.15 displays important human complement (C')-mediated cytotoxicity (CMC) against its target cells. In this study the reactivity of FC-2.15 against drug re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ballaré, C., Portela, P., Schiaffi, J., Yomha, R., Mordoh, J.
Formato: JOUR
Materias:
Adriamycin
Breast cancer
MDR
Monoclonal antibody
Taxol
antibody
antineoplastic agent
complement
cyclophosphamide
doxorubicin
epirubicin
fluorouracil
membrane antigen
monoclonal antibody
paclitaxel
tumor antigen
antigen expression
antineoplastic activity
article
blood group Lewis system
breast cancer
cancer cell
cancer cell culture
controlled study
cytolysis
cytotoxicity
female
flow cytometry
human
human cell
molecular recognition
priority journal
Antibodies, Monoclonal
Antigens, CD15
Antineoplastic Agents
Breast Neoplasms
Cell Survival
Doxorubicin
Drug Resistance, Neoplasm
Female
Humans
Paclitaxel
Tumor Cells, Cultured
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_01676806_v47_n2_p163_Ballare
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Ejemplares similares